{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:28:12Z","timestamp":1791725292904,"version":"4.3.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,3,9]],"date-time":"2018-03-09T00:00:00Z","timestamp":1520553600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81570802"],"award-info":[{"award-number":["81570802"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"CAMS Initiative for Innovative Medicine","award":["2016-I2M-3-003"],"award-info":[{"award-number":["2016-I2M-3-003"]}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"crossref","award":["2016YFC0901501"],"award-info":[{"award-number":["2016YFC0901501"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s00198-018-4448-2","type":"journal-article","created":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T23:36:28Z","timestamp":1520552188000},"page":"1389-1396","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Novel compound heterozygous mutations in SERPINH1 cause rare autosomal recessive osteogenesis imperfecta type X"],"prefix":"10.1007","volume":"29","author":[{"given":"Y.","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,9]]},"reference":[{"key":"4448_CR1","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/S0140-6736(15)00728-X","volume":"387","author":"A Forlino","year":"2016","unstructured":"Forlino A, Marini JC (2016) Osteogenesis imperfecta. Lancet 387:1657\u20131671","journal-title":"Lancet"},{"key":"4448_CR2","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.bone.2017.02.004","volume":"102","author":"J Lim","year":"2017","unstructured":"Lim J, Grafe I, Alexander S, Lee B (2017) Genetic causes and mechanisms of osteogenesis imperfecta. Bone 102:40\u201349","journal-title":"Bone"},{"key":"4448_CR3","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1097\/MOP.0000000000000117","volume":"26","author":"JC Marini","year":"2017","unstructured":"Marini JC, Reich A, Smith SM (2017) Osteogenesis imperfecta due to mutations in non-collagenous genes: lessons in the biology of bone formation. Curr Opin Pediatr 26:500\u2013507","journal-title":"Curr Opin Pediatr"},{"key":"4448_CR4","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1007\/s00198-017-4094-0","volume":"28","author":"F Lv","year":"2017","unstructured":"Lv F, Ma M, Liu W, Xu X, Song Y, Li L, Jiang Y, Wang O, Xia W, Xing X, Qiu Z, Li M (2017) A novel large fragment deletion in PLS3 causes rare X-linked early-onset osteoporosis and response to zoledronic acid. Osteoporos Int 28:2691\u20132700","journal-title":"Osteoporos Int"},{"key":"4448_CR5","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/jhg.2016.109","volume":"62","author":"XJ Xu","year":"2017","unstructured":"Xu XJ, Lv F, Liu Y, Wang JY, Ma DD, Asan, Wang JW, Song LJ, Jiang Y, Wang O, Xia WB, Xing XP, Li M (2017) Novel mutations in FKBP10 in Chinese patients with osteogenesis imperfecta and their treatment with zoledronic acid. J Hum Genet 62:205\u2013211","journal-title":"J Hum Genet"},{"key":"4448_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0107594","volume":"9","author":"P Zhou","year":"2014","unstructured":"Zhou P, Liu Y, Lv F, Nie M, Jiang Y, Wang O, Xia W, Xing X, Li M (2014) Novel mutations in FKBP10 and PLOD2 cause rare Bruck syndrome in Chinese patients. PLoS One 9:e107594","journal-title":"PLoS One"},{"key":"4448_CR7","doi-asserted-by":"publisher","unstructured":"Barbirato C, Trancozo M, Rebou\u00e7as MR, Sipolatti V, Nunes VR, Paula F (2016) Analysis of FKBP10, SERPINH1, and SERPINF1 genes in patients with osteogenesis imperfecta. Genet Mol Res 15. \n                    https:\/\/doi.org\/10.4238\/gmr.15038665","DOI":"10.4238\/gmr.15038665"},{"key":"4448_CR8","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/s00223-013-9723-9","volume":"93","author":"DR Eyre","year":"2013","unstructured":"Eyre DR, Weis MA (2013) Bone collagen: new clues to its mineralization mechanism from recessive osteogenesis imperfecta. Calcif Tissue Int 93:338\u2013347","journal-title":"Calcif Tissue Int"},{"key":"4448_CR9","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/(SICI)1096-9896(199802)184:2<212::AID-PATH996>3.0.CO;2-Z","volume":"184","author":"T Kojima","year":"1998","unstructured":"Kojima T, Miyaishi O, Saga S, Ishiguro N, Tsutsui Y, Iwata H (1998) The retention of abnormal type I procollagen and correlated expression of HSP 47 in fibroblasts from a patient with lethal osteogenesis imperfecta. J Pathol 184:212\u2013218","journal-title":"J Pathol"},{"key":"4448_CR10","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.semcdb.2016.11.005","volume":"62","author":"S Ito","year":"2017","unstructured":"Ito S, Nagata K (2017) Biology of Hsp47 (serpin H1), a collagen-specific molecular chaperone. Semin Cell Dev Biol 62:142\u2013151","journal-title":"Semin Cell Dev Biol"},{"key":"4448_CR11","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3109\/03008209309016833","volume":"29","author":"B Shroff","year":"1993","unstructured":"Shroff B, Smith T, Norris K, Pileggi R, Sauk JJ (1993) Hsp 47 is localized to regions of type I collagen production in developing murine femurs and molars. Connect Tissue Res 29:273\u2013286","journal-title":"Connect Tissue Res"},{"key":"4448_CR12","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1002\/jbmr.3095","volume":"32","author":"I Duran","year":"2017","unstructured":"Duran I, Martin JH, Weis MA, Krejci P, Konik P, Li B, Alanay Y, Lietman C, Lee B, Eyre D, Cohn DH, Krakow D (2017) A chaperone complex formed by HSP47, FKBP65, and BiP modulates telopeptide lysyl hydroxylation of type I procollagen. J Bone Miner Res 32:1309\u20131319","journal-title":"J Bone Miner Res"},{"key":"4448_CR13","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1093\/hmg\/ddu608","volume":"24","author":"I Duran","year":"2015","unstructured":"Duran I, Nevarez L, Sarukhanov A, Wu S, Lee K, Krejci P, Weis M, Eyre D, Krakow D, Cohn DH (2015) HSP47 and FKBP65 cooperate in the synthesis of type I procollagen. Hum Mol Genet 24:1918\u20131928","journal-title":"Hum Mol Genet"},{"key":"4448_CR14","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.ajhg.2010.01.034","volume":"86","author":"HE Christiansen","year":"2010","unstructured":"Christiansen HE, Schwarze U, Pyott SM, AlSwaid A, Al Balwi M, Alrasheed S, Pepin MG, Weis MA, Eyre DR, Byers PH (2010) Homozygosity for a missense mutation in SERPINH1, which encodes the collagen chaperone protein HSP47, results in severe recessive osteogenesis imperfecta. Am J Hum Genet 86:389\u2013398","journal-title":"Am J Hum Genet"},{"key":"4448_CR15","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.gene.2016.09.035","volume":"595","author":"C Marshall","year":"2016","unstructured":"Marshall C, Lopez J, Crookes L, Pollitt RC, Balasubramanian M (2016) A novel homozygous variant in SERPINH1 associated with a severe, lethal presentation of osteogenesis imperfecta with hydranencephaly. Gene 595:49\u201352","journal-title":"Gene"},{"key":"4448_CR16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/mgg3.331","volume":"6","author":"O Essawi","year":"2017","unstructured":"Essawi O, Symoens S, Fannana M, Darwish M, Farraj M, Willaert A, Essawi T, Callewaert B, De Paepe A, Malfait F, Coucke PJ (2017) Genetic analysis of osteogenesis imperfecta in the Palestinian population: molecular screening of 49 affected families. Mol Genet Genomic Med 6:15\u201326. \n                    https:\/\/doi.org\/10.1002\/mgg3.331","journal-title":"Mol Genet Genomic Med"},{"key":"4448_CR17","first-page":"487","volume":"47","author":"H Li","year":"2009","unstructured":"Li H, Ji CY, Zong XN, Zhang YQ (2009) Height and weight standardized growth charts for Chinese children and adolescents aged 0 to 18 year. Zhonghua Er Ke Za Zhi 47:487\u2013492 [Chinese]","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"4448_CR18","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1007\/s00198-017-4143-8","volume":"28","author":"Y Liu","year":"2017","unstructured":"Liu Y, Asan MD, Lv F, Xu X, Wang J, Xia W, Jiang Y, Wang O, Xing X, Yu W, Wang J, Sun J, Song L, Zhu Y, Yang H, Wang J, Li M (2017) Gene mutation spectrum and genotype-phenotype correlation in a cohort of Chinese osteogenesis imperfecta patients revealed by targeted next generation sequencing. Osteoporos Int 28:2985\u20132995","journal-title":"Osteoporos Int"},{"key":"4448_CR19","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/B978-0-12-386471-0.00009-2","volume":"499","author":"Y Ishida","year":"2011","unstructured":"Ishida Y, Nagata K (2011) Hsp47 as a collagen-specific molecular chaperone. Methods Enzymol 499:167\u2013182","journal-title":"Methods Enzymol"},{"key":"4448_CR20","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1146\/annurev.bb.20.060191.001033","volume":"20","author":"J Engel","year":"1991","unstructured":"Engel J, Prockop DJ (1991) The zipper-like folding of collagen triple helices and the effects of mutations that disrupt the zipper. Annu Rev Biophys Biophys Chem 20:137\u2013152","journal-title":"Annu Rev Biophys Biophys Chem"},{"key":"4448_CR21","doi-asserted-by":"publisher","first-page":"13243","DOI":"10.1073\/pnas.1208072109","volume":"109","author":"C Widmer","year":"2012","unstructured":"Widmer C, Gebauer JM, Brunstein E, Rosenbaum S, Zaucke F, Dr\u00f6gem\u00fcller C, Leeb T, Baumann U (2012) Molecular basis for the action of the collagen-specific chaperone Hsp47\/SERPINH1 and its structure-specific client recognition. Proc Natl Acad Sci U S A 109:13243\u201313247","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4448_CR22","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1006\/scdb.1999.0317","volume":"10","author":"SR Lamande","year":"1999","unstructured":"Lamande SR, Bateman JF (1999) Procollagen folding and assembly: the role of endoplasmic reticulum enzymes and molecular chaperones. Semin Cell Dev Biol 10:455\u2013464","journal-title":"Semin Cell Dev Biol"},{"key":"4448_CR23","doi-asserted-by":"publisher","first-page":"17679","DOI":"10.1074\/jbc.M115.661025","volume":"290","author":"U Lindert","year":"2015","unstructured":"Lindert U, Weis MA, Rai J, Seeliger F, Hausser I, Leeb T, Eyre D, Rohrbach M, Giunta C (2015) Molecular consequences of the SERPINH1\/HSP47 mutation in the dachshund natural model of osteogenesis imperfecta. J Biol Chem 290:17679\u201317689","journal-title":"J Biol Chem"},{"key":"4448_CR24","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1083\/jcb.150.6.1499","volume":"150","author":"N Nagai","year":"2000","unstructured":"Nagai N, Hosokawa M, Itohara S, Adachi E, Matsushita T, Hosokawa N, Nagata K (2000) Embryonic lethality of molecular chaperone hsp47 knockout mice is associated with defects in collagen biosynthesis. J Cell Biol 150:1499\u20131506","journal-title":"J Cell Biol"},{"key":"4448_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1000579","volume":"5","author":"C Dr\u00f6gem\u00fcller","year":"2009","unstructured":"Dr\u00f6gem\u00fcller C, Becker D, Brunner A, Haase B, Kircher P, Seeliger F, Fehr M, Baumann U, Lindblad-Toh K, Leeb T (2009) A missense mutation in the SERPINH1 gene in dachshunds with osteogenesis imperfecta. PLoS Genet 5:e1000579","journal-title":"PLoS Genet"},{"key":"4448_CR26","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.bbrc.2015.12.028","volume":"469","author":"S Ito","year":"2016","unstructured":"Ito S, Nagata K (2016) Mutants of collagen-specific molecular chaperone Hsp47 causing osteogenesis imperfecta are structurally unstable with weak binding affinity to collagen. Biochem Biophys Res Commun 469:437\u2013442","journal-title":"Biochem Biophys Res Commun"},{"key":"4448_CR27","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1016\/S0140-6736(13)61091-0","volume":"382","author":"N Bishop","year":"2013","unstructured":"Bishop N, Adami S, Ahmed SF, Ant\u00f3n J, Arundel P, Burren CP, Devogelaer JP, Hangartner T, Hossz\u00fa E, Lane JM, Lorenc R, M\u00e4kitie O, Munns CF, Paredes A, Pavlov H, Plotkin H, Raggio CL, Reyes ML, Schoenau E, Semler O, Sillence DO, Steiner RD (2013) Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebocontrolled trial. Lancet 382:1424\u20131432","journal-title":"Lancet"},{"key":"4448_CR28","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00774-013-0438-9","volume":"31","author":"GI Baroncelli","year":"2013","unstructured":"Baroncelli GI, Vierucci F, Bertelloni S, Erba P, Zampollo E, Giuca MR (2013) Pamidronate treatment stimulates the onset of recovery phase reducing fracture rate and skeletal deformities in patients with idiopathic juvenile osteoporosis: comparison with untreated patients. J Bone Miner Metab 31:533\u2013543","journal-title":"J Bone Miner Metab"},{"key":"4448_CR29","doi-asserted-by":"publisher","unstructured":"Dwan K, Phillipi CA, Steiner RD, Basel D (2016) Bisphosphonate therapy for osteogenesis imperfecta. Cochrane Database Syst Rev 10:CD005088. \n                    https:\/\/doi.org\/10.1002\/14651858.CD005088.pub4","DOI":"10.1002\/14651858.CD005088.pub4"},{"key":"4448_CR30","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.4158\/EP161322.OR","volume":"22","author":"F Lv","year":"2016","unstructured":"Lv F, Liu Y, Xu X, Wang J, Ma D, Jiang Y, Wang O, Xia W, Xing X, Yu W, Li M (2016) Effects of long-term alendronate treatment on a large sample of pediatric patients with osteogenesis imperfecta. Endocr Pract 22:1369\u20131376","journal-title":"Endocr Pract"},{"key":"4448_CR31","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1002\/jbmr.2567","volume":"30","author":"T Palomo","year":"2015","unstructured":"Palomo T, Fassier F, Ouellet J, Sato A, Montpetit K, Glorieux FH, Rauch F (2015) Intravenous bisphosphonate therapy of young children with osteogenesis imperfecta: skeletal findings during follow up throughout the growing years. J Bone Miner Res 30:2150\u20132157","journal-title":"J Bone Miner Res"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-018-4448-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-018-4448-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-018-4448-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T03:48:21Z","timestamp":1589860101000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-018-4448-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,9]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["4448"],"URL":"https:\/\/doi.org\/10.1007\/s00198-018-4448-2","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,9]]},"assertion":[{"value":"30 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Scientific Research Ethics Committee of PUMCH, and the parents of the patient signed informed consent before they participated in this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}